➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Dow
McKesson
Baxter
Boehringer Ingelheim

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Patent: 10,118,901

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,118,901
Title:Therapeutic agents
Abstract: The present invention relates to a class of hydroxamic acid compounds of Formula (I), which act as alkylating agents and/or inhibitors of the HDAC pathway, having potential utility in the treatment of a neoplastic disease and immune diseases. ##STR00001##
Inventor(s): Chen; Yu (San Jose, CA), Chen; Yi (Pleasanton, CA)
Assignee: Purdue Pharmaceutical Products L.P. (Stamford, CT)
Application Number:14/374,995
Patent Claims:see list of patent claims

Details for Patent 10,118,901

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22 ⤷  Free Forever Trial Purdue Pharmaceutical Products L.P. (Stamford, CT) 2039-02-26 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22 ⤷  Free Forever Trial Purdue Pharmaceutical Products L.P. (Stamford, CT) 2039-02-26 RX Orphan search
Bristol Myers Squibb EMPLICITI elotuzumab INJECTABLE;INJECTION 761035 002 2015-11-30 ⤷  Free Forever Trial Purdue Pharmaceutical Products L.P. (Stamford, CT) 2039-02-26 RX Orphan search
Bristol Myers Squibb EMPLICITI elotuzumab INJECTABLE;INJECTION 761035 001 2015-11-30 ⤷  Free Forever Trial Purdue Pharmaceutical Products L.P. (Stamford, CT) 2039-02-26 RX Orphan search
Novartis KESIMPTA ofatumumab SOLUTION;SUBCUTANEOUS 125326 002 2009-10-26 ⤷  Free Forever Trial Purdue Pharmaceutical Products L.P. (Stamford, CT) 2039-02-26 RX Orphan search
Novartis ARZERRA ofatumumab INJECTABLE; INJECTION 125326 001 2009-10-26 ⤷  Free Forever Trial Purdue Pharmaceutical Products L.P. (Stamford, CT) 2039-02-26 RX Orphan search
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 002 1997-11-26 ⤷  Free Forever Trial Purdue Pharmaceutical Products L.P. (Stamford, CT) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,118,901

Country Patent Number Estimated Expiration
South Africa 201405764 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2013113838 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2013113841 ⤷  Free Forever Trial
United States of America 2015086551 ⤷  Free Forever Trial
Taiwan 201343632 ⤷  Free Forever Trial
Taiwan I573792 ⤷  Free Forever Trial
Slovenia 2809657 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
McKesson
Medtronic
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.